Curanex Pharmaceuticals Inc
CURX
$0.62
$0.011.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -435.00K | -418.90K | -361.50K | -237.00K | -137.10K |
| Total Depreciation and Amortization | 29.60K | 14.60K | -- | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.30K | 74.70K | 74.70K | -- | -100.00 |
| Change in Net Operating Assets | -330.20K | -282.00K | -268.70K | -223.20K | -193.20K |
| Cash from Operations | -665.30K | -611.50K | -555.50K | -460.20K | -330.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 400.00K | 200.00K | -- | 3.00K | 3.00K |
| Total Debt Repaid | -- | -- | -- | 2.00K | 0.00 |
| Issuance of Common Stock | 0.00 | 580.00K | 630.00K | 699.10K | 699.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 400.00K | 780.10K | 630.10K | 704.20K | 702.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -265.30K | 168.60K | 74.60K | 244.00K | 371.80K |